Literature DB >> 1416825

Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga.

F L Schuster1, L S Jacob.   

Abstract

Amebic keratitis produced by Acanthamoeba spp. is an increasingly important ocular infection in extended-use contact lens wearers. Problems associated with the infection are compounded by the lack of effective and well-tolerated chemotherapeutic agents. The magainins, a group of naturally occurring and synthetic membrane-active peptide compounds, have been shown to be active in vitro against a clinical isolate of Acanthamoeba polyphaga. Two magainins tested extensively had minimal inhibitory and minimal amebicidal values of 20 and 25 micrograms/ml for magainin MSI-103 and 25 and 40 micrograms/ml for magainin MSI-94, respectively. Both amebastatic and amebicidal activities are enhanced by combining the magainins with silver nitrate (200 micrograms/ml) and/or other marginally effective antimicrobial agents. These combinations have activity against both trophic and cystic stages in the Acanthamoeba life cycle and have promise as antimicrobial agents in the treatment of amebic keratitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416825      PMCID: PMC190329          DOI: 10.1128/AAC.36.6.1263

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Effect of magainins on Acanthamoeba castellanii.

Authors:  S T Feldman; M Speaker; P Cleveland
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

Review 2.  In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba.

Authors:  M S Osato; N M Robinson; K R Wilhelmus; D B Jones
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

Review 3.  Magainins: a new family of membrane-active host defense peptides.

Authors:  B A Berkowitz; C L Bevins; M A Zasloff
Journal:  Biochem Pharmacol       Date:  1990-02-15       Impact factor: 5.858

Review 4.  Naegleria and Acanthamoeba infections: review.

Authors:  P Ma; G S Visvesvara; A J Martinez; F H Theodore; P M Daggett; T K Sawyer
Journal:  Rev Infect Dis       Date:  1990 May-Jun

5.  Drug sensitivity and resistance of four Acanthamoeba species.

Authors:  A R Stevens; E Willaert
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

6.  Oral itraconazole and topical miconazole with débridement for Acanthamoeba keratitis.

Authors:  Y Ishibashi; Y Matsumoto; T Kabata; R Watanabe; S Hommura; K Yasuraoka; K Ishii
Journal:  Am J Ophthalmol       Date:  1990-02-15       Impact factor: 5.258

7.  Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management.

Authors:  M B Moore; J P McCulley
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

8.  Acanthamoeba keratitis in non-contact lens wearers.

Authors:  S Sharma; M Srinivasan; C George
Journal:  Arch Ophthalmol       Date:  1990-05

9.  Laboratory investigation of Acanthamoeba keratitis.

Authors:  S Kilvington; D F Larkin; D G White; J R Beeching
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

10.  Chemotherapeutic compounds and Acanthamoebae from eye infections.

Authors:  J Nagington; J E Richards
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

View more
  9 in total

1.  Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.

Authors:  C B Park; K S Yi; K Matsuzaki; M S Kim; S C Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Role of positional hydrophobicity in the leishmanicidal activity of magainin 2.

Authors:  Esther Guerrero; José María Saugar; Katsumi Matsuzaki; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Defensins and other antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

4.  In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea.

Authors:  S Gatti; C Cevini; A Bruno; G Penso; P Rama; M Scaglia
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 5.  Role of host-defence peptides in eye diseases.

Authors:  Satya S Kolar; Alison M McDermott
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

6.  The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.

Authors:  Mark J Mannis
Journal:  Trans Am Ophthalmol Soc       Date:  2002

Review 7.  Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs.

Authors:  Hany M Elsheikha; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Pathogens       Date:  2020-05-22

8.  Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae.

Authors:  Noor Akbar; Wendy E Kaman; Maarten Sarink; Kamran Nazmi; Floris J Bikker; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  ACS Omega       Date:  2022-08-10

9.  Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae.

Authors:  J Michael Conlon; Milena Mechkarska
Journal:  Pharmaceuticals (Basel)       Date:  2014-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.